Humanin ameliorates diabetes-induced testicular damage, restoring antioxidant balance and tissue integrity in STZ-mice
Background
Diabetes mellitus is a pervasive metabolic disorder frequently linked to oxidative stress and significant male reproductive dysfunction. Current treatments often fall short in fully protecting delicate reproductive tissues from diabetes-induced damage. Humanin, a unique mitochondria-derived peptide, is recognized for its potent cytoprotective, anti-apoptotic, and antioxidant properties across various disease models. However, its specific role in mitigating diabetes-induced testicular damage, a critical gap in male fertility preservation, has remained largely unexplored, prompting this investigation into its protective potential.
Study Design
This study investigated Humanin's effects on streptozotocin (STZ)-induced diabetic mice. 40 adult male Balb/C mice were divided into four groups (n=10 per group): Control, Humanin (HN), STZ, and STZ+HN. Diabetes was induced via a single intraperitoneal (IP) administration of STZ (150 mg/kg). Following diabetes induction, Humanin (4 mg/kg) was administered IP daily for 15 days to the STZ+HN group. Primary endpoints included measuring total antioxidant status (TAS), total oxidant status (TOS), and glutathione (GSH) levels in seminal vesicle fluid using ELISA, alongside comprehensive histopathological and histomorphometric evaluation of testicular tissues.
Results
STZ-induced diabetes significantly disrupted the oxidative balance in seminal vesicle fluid, evidenced by a substantial decrease in TAS and GSH levels and a marked increase in TOS levels (P < 0.05). Humanin treatment effectively reversed these detrimental changes. Compared to the STZ group, Humanin significantly increased TAS and GSH levels while concurrently reducing TOS levels (P < 0.05), indicating a restoration of antioxidant capacity. Histopathological analysis revealed severe damage in diabetic mice, including seminiferous tubule degeneration, significant germ cell loss, interstitial oedema, and vascular congestion. However, these structural and cellular abnormalities were profoundly ameliorated in the Humanin-treated diabetic group. Histomorphometric abnormalities associated with diabetes were also significantly improved by Humanin.
Humanin treatment effectively attenuated diabetes-induced oxidative imbalance and reversed severe testicular histopathological damage in STZ-induced diabetic mice, demonstrating a robust protective effect.
Key Findings
- STZ-induced diabetes significantly decreased seminal vesicle fluid
TASandGSHlevels (P < 0.05). - STZ-induced diabetes significantly increased seminal vesicle fluid
TOSlevels (P < 0.05). - Humanin treatment significantly increased
TASandGSHlevels in diabetic mice (P < 0.05). - Humanin treatment significantly reduced
TOSlevels in diabetic mice (P < 0.05). - Humanin ameliorated diabetes-induced seminiferous tubule degeneration, germ cell loss, interstitial oedema, and vascular congestion.
Why It Matters
This research suggests Humanin could be a promising therapeutic strategy for preserving male fertility in individuals with diabetes. For biohackers and clinicians, this opens a new avenue for mitigating a common and distressing complication of diabetes. While this is a preclinical animal study, the clear reversal of both biochemical and structural damage indicates a strong potential for clinical translation. Future protocols might incorporate Humanin to protect reproductive health in diabetic patients, potentially as an adjunctive therapy. The explicit dosing and duration in this study provide a foundational basis for further research into a usable protocol, moving beyond current standard-of-care limitations that often fail to adequately address testicular damage.
humanin
diabetes
testicular-damage
oxidative-stress
male-fertility
preclinical-animal